The emerging role of microRNAs in Alzheimer's disease

Frontiers in Physiology

Volumn 6, Issue FEB, 2015, Pages

  Femminella, Grazia D ^a   Ferrara, Nicola ^a   Rengo, Giuseppe ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS   (Italy)

Author keywords

Alzheimer's disease; Biomarker; Functional recovery; Gene expression; MicroRNAs; Neurodegeneration

Indexed keywords

ADAM10 ENDOPEPTIDASE; BETA SECRETASE 1; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 5; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FRACTALKINE; MICRORNA; MICRORNA 106; MICRORNA 107; MICRORNA 124; MICRORNA 125B; MICRORNA 132; MICRORNA 137; MICRORNA 146A; MICRORNA 153; MICRORNA 155; MICRORNA 181; MICRORNA 181C; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 34; MICRORNA 9; RAS PROTEIN; SIRTUIN 1; SOMATOMEDIN C; TAU PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REST; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; DIAGNOSTIC VALUE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; MOLECULAR PATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; PROTEIN TARGETING; REVIEW; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 84926480089     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00040     Document Type: Review

References (34)

1. Alexandrov, P. N., Dua, P., Hill, J. M., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J. (2012). microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365-373.
2. Bonda, D. J., Lee, H. G., Camins, A., Pallas, M., Casadesus, G., Smith, M. A., et al. (2011). The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 10, 275-279. doi: 10.1016/S1474-4422(11)70013-8
3. Chen, X., Liang, H., Zhang, J., Zen, K., and Zhang, C. Y. (2012). Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 22, 125-132. doi: 10.1016/j.tcb.2011.12.001
4. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimer's Dis. 14, 27-41.
5. Danborg, P. B., Simonsen, A. H., Waldemar, G., and Heegaard, N. H. (2014). The potential of microRNAs as biofluid markers of neurodegenerative diseases-a systematic review. Biomarkers 19, 259-268. doi: 10.3109/1354750X.2014.904001
6. Demetrius, L. A., and Driver, J. (2013). Alzheimer's as a metabolic disease. Biogerontology 14, 641-649. doi: 10.1007/s10522-013-9479-7
7. Dineley, K. T., Jahrling, J. B., and Denner, L. (2014). Insulin resistance in Alzheimer's disease. Neurobiol. Dis. 72, 92-103. doi: 10.1016/j.nbd.2014.09.001
8. Dorval, V., Nelson, P. T., and Hebert, S. S. (2013). Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers. Front. Mol. Neurosci. 6:24. doi: 10.3389/fnmol.2013.00024
9. Femminella, G. D., and Edison, P. (2014). Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging. Alzheimer's Dement. 10(1 Suppl.), S55-S61. doi: 10.1016/j.jalz.2013.12.012
10. Femminella, G. D., Rengo, G., Komici, K., Iacotucci, P., Petraglia, L., Pagano, G., et al. (2014). Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature. J. Alzheimer's Dis. 42, 369-377. doi: 10.3233/JAD-140513
11. Femminella, G. D., Rengo, G., Pagano, G., de Lucia, C., Komici, K., Parisi, V., et al. (2013). beta-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? J. Alzheimer's Dis. 34, 341-347. doi: 10.3233/JAD-121813
12. Geekiyanage, H., Jicha, G. A., Nelson, P. T., and Chan, C. (2012). Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 235, 491-496. doi: 10.1016/j.expneurol.2011.11.026
13. Goodall, E. F., Heath, P. R., Bandmann, O., Kirby, J., and Shaw, P. J. (2013). Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front. Cell. Neurosci. 7:178. doi: 10.3389/fncel.2013.00178
14. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420. doi: 10.1073/pnas.0710263105
15. Hooper, C., Meimaridou, E., Tavassoli, M., Melino, G., Lovestone, S., and Killick, R. (2007). p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neurosci. Lett. 418, 34-37. doi: 10.1016/j.neulet.2007.03.026
16. Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., et al. (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer's Dement. 8, 1-13. doi: 10.1016/j.jalz.2011.10.007
17. Jack, C. R. Jr., and Holtzman, D. M. (2013). Biomarker modeling of Alzheimer's disease. Neuron 80, 1347-1358. doi: 10.1016/j.neuron.2013.12.003
18. Kim, D. H., Yeo, S. H., Park, J. M., Choi, J. Y., Lee, T. H., Park, S. Y., et al. (2014). Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Gene 545, 185-193. doi: 10.1016/j.gene.2014.05.031
19. Kim, J., Yoon, H., Ramirez, C. M., Lee, S. M., Hoe, H. S., Fernandez-Hernando, C., et al. (2012). MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp. Neurol. 235, 476-483. doi: 10.1016/j.expneurol.2011.11.010
20. Krichevsky, A. M., King, K. S., Donahue, C. P., Khrapko, K., and Kosik, K. S. (2003). A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9, 1274-1281. doi: 10.1261/rna.5980303
21. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414. doi: 10.1016/j.cell.2007.04.040
22. Lehmann, S. M., Kruger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., et al. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827-835. doi: 10.1038/nn.3113
23. Lukiw, W. J., and Alexandrov, P. N. (2012). Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol. Neurobiol. 46, 11-19. doi: 10.1007/s12035-012-8234-4
24. Lukiw, W. J., Alexandrov, P. N., Zhao, Y., Hill, J. M., and Bhattacharjee, S. (2012). Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport 23, 621-626. doi: 10.1097/WNR.0b013e32835542b0
25. Maciotta, S., Meregalli, M., and Torrente, Y. (2013). The involvement of microRNAs in neurodegenerative diseases. Front. Cell. Neurosci. 7:265. doi: 10.3389/fncel.2013.00265
26. Nelson, P. T., and Wang, W. X. (2010). MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimer's Dis. 21, 75-79. doi: 10.3233/JAD-2010-091603
27. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Biol. 1, 263-274.
28. Schonrock, N., Humphreys, D. T., Preiss, T., and Gotz, J. (2012a). Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta. J. Mol. Neurosci. 46, 324-335. doi: 10.1007/s12031-011-9587-2
29. Schonrock, N., Matamales, M., Ittner, L. M., and Gotz, J. (2012b). MicroRNA networks surrounding APP and amyloid-beta metabolism-implications for Alzheimer's disease. Exp. Neurol. 235, 447-454. doi: 10.1016/j.expneurol.2011.11.013
30. Schwarzenbach, H., Nishida, N., Calin, G. A., and Pantel, K. (2014). Clinical relevance of circulating cell-free microRNAs in cancer. Nat. Rev. Clin. Oncol. 11, 145-156. doi: 10.1038/nrclinonc.2014.5
31. Sethi, P., and Lukiw, W. J. (2009). Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 459, 100-104. doi: 10.1016/j.neulet.2009.04.052
32. Van den Hove, D. L., Kompotis, K., Lardenoije, R., Kenis, G., Mill, J., Steinbusch, H. W., et al. (2014). Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiol. Aging 35, 731-745. doi: 10.1016/j.neurobiolaging.2013.10.082
33. Wang, W. X., Huang, Q., Hu, Y., Stromberg, A. J., and Nelson, P. T. (2011). Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 121, 193-205. doi: 10.1007/s00401-010-0756-0
34. Zovoilis, A., Agbemenyah, H. Y., Agis-Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., et al. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308. doi: 10.1038/emboj.2011.327